NHS to offer weight-loss jabs to heart attack survivors

England's NHS will begin offering anti-obesity injections to patients at risk of further heart attacks or strokes, expanding GLP-1 drug access beyond weight loss to active cardiovascular prevention. The rollout targets more than one million people and represents one of the NHS's largest expansions of the drug class yet. It follows mounting evidence that the jabs reduce serious cardiac events independently of weight reduction.

More from today's briefing

World

Trump says US-Iran war ends in weeks, deal irrelevant

Politics

Trump signs executive order restricting mail-in voting

Tech

Oracle fires 30,000 workers by 6am email

Science

Artemis II moon mission cleared for imminent launch